David Roman
Stock Analyst at Goldman Sachs
(1.87)
# 3,221
Out of 4,944 analysts
44
Total ratings
37.5%
Success rate
-5.73%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Initiates: Buy | $29 | $20.09 | +44.35% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $89.27 | +16.50% | 3 | Jun 4, 2025 | |
| BBNX Beta Bionics | Initiates: Neutral | $16 | $15.10 | +5.96% | 1 | May 30, 2025 | |
| PODD Insulet | Initiates: Buy | $380 | $308.68 | +23.10% | 1 | May 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $80 → $50 | $64.02 | -21.90% | 3 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $120 → $104 | $103.22 | +0.76% | 2 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $13 → $10 | $7.44 | +34.41% | 4 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $94 → $82 | $75.33 | +8.85% | 3 | May 1, 2025 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $24 → $23 | $15.89 | +44.75% | 2 | Apr 16, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $138 → $154 | $129.40 | +19.01% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $11.13 | +115.63% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $74.38 | -4.54% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $53.06 | +3.66% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $24.11 | +74.20% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $91 → $124 | $166.86 | -25.69% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $378.95 | +12.68% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $77.68 | +15.86% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $102.50 | -12.20% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $482.35 | +3.66% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $195.96 | +39.82% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $92.91 | -10.67% | 1 | May 30, 2024 |
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $20.09
Upside: +44.35%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $89.27
Upside: +16.50%
Beta Bionics
May 30, 2025
Initiates: Neutral
Price Target: $16
Current: $15.10
Upside: +5.96%
Insulet
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $308.68
Upside: +23.10%
Doximity
May 21, 2025
Maintains: Neutral
Price Target: $80 → $50
Current: $64.02
Upside: -21.90%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $103.22
Upside: +0.76%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.44
Upside: +34.41%
GE HealthCare Technologies
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $75.33
Upside: +8.85%
Kestra Medical Technologies
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $15.89
Upside: +44.75%
Abbott Laboratories
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $129.40
Upside: +19.01%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $11.13
Upside: +115.63%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $74.38
Upside: -4.54%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $53.06
Upside: +3.66%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $24.11
Upside: +74.20%
Feb 24, 2025
Maintains: Neutral
Price Target: $91 → $124
Current: $166.86
Upside: -25.69%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $378.95
Upside: +12.68%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $77.68
Upside: +15.86%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $102.50
Upside: -12.20%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $482.35
Upside: +3.66%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $195.96
Upside: +39.82%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $92.91
Upside: -10.67%